BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37327088)

  • 1. A targetable pathway to eliminate TRA-1-60+/TRA-1-81+ chemoresistant cancer cells.
    Tan L; Duan X; Mutyala P; Zhou T; Amin S; Zhang T; Herbst B; Askan G; Itkin T; Xiang Z; Michelassi F; Lieberman MD; Iacobuzio-Donahue CA; Leach SD; Evans T; Chen S
    J Mol Cell Biol; 2023 Nov; 15(6):. PubMed ID: 37327088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An epithelial cell adhesion molecule- and CD3-bispecific antibody plus activated T-cells can eradicate chemoresistant cancer stem-like pancreatic carcinoma cells in vitro.
    Umebayashi M; Kiyota A; Koya N; Tanaka H; Onishi H; Katano M; Morisaki T
    Anticancer Res; 2014 Aug; 34(8):4509-19. PubMed ID: 25075094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SRGN crosstalks with YAP to maintain chemoresistance and stemness in breast cancer cells by modulating HDAC2 expression.
    Zhang Z; Qiu N; Yin J; Zhang J; Liu H; Guo W; Liu M; Liu T; Chen D; Luo K; Li H; He Z; Liu J; Zheng G
    Theranostics; 2020; 10(10):4290-4307. PubMed ID: 32292495
    [No Abstract]   [Full Text] [Related]  

  • 4. Ubiquitin-Specific Peptidase 22 Contributes to Colorectal Cancer Stemness and Chemoresistance via Wnt/β-Catenin Pathway.
    Jiang S; Song C; Gu X; Wang M; Miao D; Lv J; Liu Y
    Cell Physiol Biochem; 2018; 46(4):1412-1422. PubMed ID: 29689565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of transmembrane protein 98 as a novel chemoresistance-conferring gene in hepatocellular carcinoma.
    Ng KT; Lo CM; Guo DY; Qi X; Li CX; Geng W; Liu XB; Ling CC; Ma YY; Yeung WH; Shao Y; Poon RT; Fan ST; Man K
    Mol Cancer Ther; 2014 May; 13(5):1285-97. PubMed ID: 24608572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex Determining Region Y Box 9 Induces Chemoresistance in Pancreatic Cancer Cells by Induction of Putative Cancer Stem Cell Characteristics and Its High Expression Predicts Poor Prognosis.
    Higashihara T; Yoshitomi H; Nakata Y; Kagawa S; Takano S; Shimizu H; Kato A; Furukawa K; Ohtsuka M; Miyazaki M
    Pancreas; 2017; 46(10):1296-1304. PubMed ID: 28984791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PARP-1 regulates resistance of pancreatic cancer to TRAIL therapy.
    Yuan K; Sun Y; Zhou T; McDonald J; Chen Y
    Clin Cancer Res; 2013 Sep; 19(17):4750-9. PubMed ID: 23833311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global proteomic profiling identifies etoposide chemoresistance markers in non-small cell lung carcinoma.
    Paul D; Chanukuppa V; Reddy PJ; Taunk K; Adhav R; Srivastava S; Santra MK; Rapole S
    J Proteomics; 2016 Apr; 138():95-105. PubMed ID: 26898345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer.
    Yuan K; Yong S; Xu F; Zhou T; McDonald JM; Chen Y
    Oncotarget; 2015 Sep; 6(28):25308-19. PubMed ID: 26320171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CLPTM1L/CRR9 ectodomain interaction with GRP78 at the cell surface signals for survival and chemoresistance upon ER stress in pancreatic adenocarcinoma cells.
    Clarke WR; Amundadottir L; James MA
    Int J Cancer; 2019 Mar; 144(6):1367-1378. PubMed ID: 30468251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-targeted knockdown of CD44 improves cisplatin sensitivity of chemoresistant non-small cell lung cancer cells.
    Quan YH; Lim JY; Choi BH; Choi Y; Choi YH; Park JH; Kim HK
    Cancer Chemother Pharmacol; 2019 Mar; 83(3):399-410. PubMed ID: 30515553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of eIF4F Translation Initiation Complex by the Peptidyl Prolyl Isomerase FKBP7 in Taxane-resistant Prostate Cancer.
    Garrido MF; Martin NJ; Bertrand M; Gaudin C; Commo F; El Kalaany N; Al Nakouzi N; Fazli L; Del Nery E; Camonis J; Perez F; Lerondel S; Le Pape A; Compagno D; Gleave M; Loriot Y; Désaubry L; Vagner S; Fizazi K; Chauchereau A
    Clin Cancer Res; 2019 Jan; 25(2):710-723. PubMed ID: 30322877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sec62 promotes stemness and chemoresistance of human colorectal cancer through activating Wnt/β-catenin pathway.
    Liu X; Su K; Sun X; Jiang Y; Wang L; Hu C; Zhang C; Lu M; Du X; Xing B
    J Exp Clin Cancer Res; 2021 Apr; 40(1):132. PubMed ID: 33858476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with a multi-antigen targeted DNA vaccine eliminates chemoresistant pancreatic cancer by disrupting tumor-stromal cell crosstalk.
    Qin H; Chen J; Bouchekioua-Bouzaghou K; Meng YM; Griera JB; Jiang X; Kong X; Wang M; Xu Q; Wong PP
    J Transl Med; 2023 Oct; 21(1):702. PubMed ID: 37814317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoresistance Transmission via Exosome-Mediated EphA2 Transfer in Pancreatic Cancer.
    Fan J; Wei Q; Koay EJ; Liu Y; Ning B; Bernard PW; Zhang N; Han H; Katz MH; Zhao Z; Hu Y
    Theranostics; 2018; 8(21):5986-5994. PubMed ID: 30613276
    [No Abstract]   [Full Text] [Related]  

  • 16. A pre-existing population of ZEB2
    Francescangeli F; Contavalli P; De Angelis ML; Careccia S; Signore M; Haas TL; Salaris F; Baiocchi M; Boe A; Giuliani A; Tcheremenskaia O; Pagliuca A; Guardiola O; Minchiotti G; Colace L; Ciardi A; D'Andrea V; La Torre F; Medema J; De Maria R; Zeuner A
    J Exp Clin Cancer Res; 2020 Jan; 39(1):2. PubMed ID: 31910865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA expression patterns in chemoresistant breast cancer tissues.
    Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
    Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA GSTM3TV2 upregulates LAT2 and OLR1 by competitively sponging let-7 to promote gemcitabine resistance in pancreatic cancer.
    Xiong G; Liu C; Yang G; Feng M; Xu J; Zhao F; You L; Zhou L; Zheng L; Hu Y; Wang X; Zhang T; Zhao Y
    J Hematol Oncol; 2019 Sep; 12(1):97. PubMed ID: 31514732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AKAP8L enhances the stemness and chemoresistance of gastric cancer cells by stabilizing SCD1 mRNA.
    Zhang R; Liu L; Wang F; Zhao W; Liu K; Yu H; Zhao S; Xu B; Zhang X; Chai J; Hao J
    Cell Death Dis; 2022 Dec; 13(12):1041. PubMed ID: 36522343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-133b suppresses colorectal cancer cell stemness and chemoresistance by targeting methyltransferase DOT1L.
    Lv L; Li Q; Chen S; Zhang X; Tao X; Tang X; Wang S; Che G; Yu Y; He L
    Exp Cell Res; 2019 Dec; 385(1):111597. PubMed ID: 31525340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.